Group A patients were given a single intravenous dose of 600 mg of teicoplanin 1 h pre-operatively. Group B patients were given a single intravenous dose of 600 mg of teicoplanin 12 h pre-operatively.
Group C patients were given a single intravenous dose of 600 mg of teicoplanin 24 h pre-operatively.
Group D patients were given an intravenous dose of 600 mg of teicoplanin 48 h pre-operatively and another dose 24 h pre-operatively. Group E patients had teicoplanin drops (2'Yc,) instilled every half hour for the 6 h preceding surgery. These patients also had cyclopentolate 1 % and phenylephrine 2.5% drops instilled six times over the hour preceding surgery. In those cases where intravenous teicoplanin had been administered a serum specimen was obtained during vitrectomy. All specimens were stored at -70°C until assays were performed.
Teicoplanin was assayed using a large plate biological assay by the agar diffusion method with the Oxford Staphylococcus aureus as the indicator organism (105 cfu/ml) poured onto Antibiotic Medium no. 2 (Merck) adjusted to pH 5.6.12 For serum samples, working standards over the range 2-64 mg/l were prepared in pooled human sera (Sigma). For vitreal samples the working standards were prepared in phosphate buffer over the range 0.25-8 mg/1. The accuracy of the reference standards was confirmed by a reference laboratory. The zone sizes were read by Vernier callipers and the results calculated by the method of Perkins. I' The sensitivity of the assay was 0.5 mg/l in both serum and vitreous. The coefficients of variation were 6.1 % and 1O.7°, {, for high and low serum controls and 6.7% and 11.5% for high and low vitreous controls, respectively. 
Results
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There was no significant relationship between the magnitude of serum and vitreous levels of teicoplanin (Pearson correlation coefficient = -0.29, 1'>0.2; Table 1 ). There were 4 cases in which significant ocular inflammation was recorded pre-operatively (Table 1) .
Renal function as assessed by serum urea and electrolytes was within normal limits in each case.
Teicoplanin was not detectable in any of the vitreous specimens following its topical administration (Table 2) . Despite this the levels of teicoplanin achieved in the We have demonstrated that inadequate vitreous levels of teicoplanin are achieved by intravenous injection alone and, therefore, that intravitreal injection is essential to achieve sufficient concentrations of antibiotic quickly.
There may be a role for systemic administration of teicoplanin to augment intravitreal injection once sensitivities on the Aspergillus isolated at this time were identical to those from the previous culture. After This small case series demonstrates that, in selected cases, surgical intervention improves the outcome of this potentially devastating disorder.
